Claims
- 1. A process for alleviating proliferative skin diseases which comprises administering to the afflicted human or animal a composition containing as its active component at least one of the compounds selected from the group represented by the formula: ##STR22## where R is hydrogen or --CH.sub.2 CHOHCH.sub.2 OH, X is lower alkyl of from 1 to 8 carbon atoms, lower alkoxy of from 1 to 8 carbon atoms, chloro, bromo or NO.sub.2, Y is chloro, bromo, NO.sub.2 or lower alkyl of from 1 to 8 carbon atoms, Z is hydrogen, halogen, CF.sub.3 or lower alkyl of from 1 to 8 carbon atoms inclusive;
- said compound being in association with a pharmaceutical carrier wherein said active component is present in an amount in the range of about 0.1 to about 15% w/v which is effective to alleviate proliferative skin disease.
- 2. A process in accordance with claim 1 wherein said active component was administered in conjunction with a permissive dosage of a glucocorticoid.
CROSS-REFERENCE TO RELATED APPLICATION
This application is a Division of Ser. No. 646,633 filed Jan. 5, 1976, and now U.S. Pat. No. 4,034,087; which was a continuation-in-part of Ser. No. 425,065, filed Dec. 12, 1973, now abandoned; and which was a continuation-in-part of Ser. No. 324,012, filed Jan. 16, 1973, now abandoned.
Non-Patent Literature Citations (1)
Entry |
hoffmann et al.-Chem. Abst. vol. 77 (1972) p. 5339S. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
646633 |
Jan 1976 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
425065 |
Dec 1973 |
|
Parent |
324012 |
Jan 1973 |
|